Skip to main content

Table 1 Summary of rFVIIa treated cardiac surgery patients (CSP) who survived >4 hours

From: Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage

P#

Age sex

Procedure

Co-morbidities

Response to rFVIIa

Outcome

   

CPB

EF%

Pre rFVIIa

Post rFVIIa

 
     

R

P

F

C

R

P

F

C

 

1

75M

CABG

-

>45

18

18

8

10

0

4

0

0

Survived

13

36M

Aortic arch repair

+

>45

28

18

16

10

6

19

20

10

Died

14

64M

Aortic dissection

-

>45

39

37

32

50

2

6

4

0

Survived

17

63M

AVR/MVR repair

-

<25

7

18

16

15

1

12

6

0

Survived

18

70M

CABG

+

>25

6

20

20

20

0

0

0

0

Survived

20

72M

CABG

-

>25

21

12

10

0

0

0

0

0

Survived

24*

79M

CABG

+

>25

10

12

12

10

5

4

4

0

Died

27*

64M

CABG, IVAD

+

<25

30

30

33

20

28

16

28

20

Died

30

85M

CABG, ruptured aorta

+

>45

13

12

6

10

3

6

8

0

Died

32*

83M

CABG

+

>25

5

18

18

10

6

18

20

0

Died

33

78F

Ruptured aorta

+

<25

14

18

20

20

3

12

6

0

Died

35*

54M

Aortic arch repair

+

>45

9

6

18

10

15

24

12

20

Survived

Average

17

18

18

15

6

10

9

4

 

P value

    

.009

.038

.009

.03

 
  1. P: Patient
  2. R: Red Blood Cell; P: Platelet; F: Fresh Frozen Plasma; C: Cryoprecipitate
  3. M: Male; F: Female
  4. CPB: Cardiopulmonary Bypass
  5. EF: Left Ventricular Ejection Fraction
  6. CABG: Coronary Artery Bypass Graft
  7. AVR: Aortic Valve Replacement
  8. MVR: Mitral Valve Replacement
  9. IVAD: Intraventricular Assisted Device
  10. * Patient continued to require blood transfusion past 24 hours post rFVIIa treatment.